Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

New cash-paying patients can now access Wegovy/Ozempic for $199 a month. Here's what that means for Novo Nordisk stock.

Dow Jones Top Company Headlines at 11 AM ET: Novo Nordisk Cuts Prices for Obesity Drugs | Deutsche ... The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic ...

Novo Nordisk is lowering the price it charges customers who pay out-of-pocket for the weight loss drugs. Mr. Funk was the ...

Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...

The cash price for popular weight-loss medication Wegovy is dropping by 30% in U.S. on Monday, according to Novo Nordisk.

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...

Shares of Hims & Hers are trading marginally lower Monday morning, as competitive news overshadows bullish announcements from ...

Novo Nordisk lowers Wegovy prices to $349 a month and adds temporary discounts, but doctors say costs remain tough for ...

Novo revealed Monday that the self-pay cost for the two lowest dosages of Wegovy and Ozempic will be $349 per month, down ...

Novo Nordisk announced it is cutting the cash-pay pricing for its popular semaglutide drugs: Wegovy will now be offered at ...

President Donald Trump has again hinted at plans to replace the Affordable Care Act, teasing a possible Republican ...